EC Number   |
Application |
Reference |
|---|
   3.4.22.B30 | drug development |
the development of inhibitors against calpain-10 may be useful as therapeutic agents for a number of calpainopathies |
731687 |
| 3.4.22.B30 | medicine |
111/121 diplotype of calpain-10 is associated with the risk of polycystic ovary syndrome in Korean women |
692406 |
| 3.4.22.B30 | medicine |
calpain-10 is the first diabetes gene that can be identified through a genome scan |
664720, 666361 |
| 3.4.22.B30 | medicine |
calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians |
677469 |
| 3.4.22.B30 | medicine |
CAPN10 gene variants rs3792267, rs3749166 and rs5030952 may affect type 2 diabetes mellitus susceptibility in the Irish population |
708822 |
| 3.4.22.B30 | medicine |
genetic variation in calpain 10 (the minor allele of single nucleotide polymorphism-43 (rs3792267) in intron 3) is associated with increased risk of pancreatic cance among smokers |
709330 |
| 3.4.22.B30 | medicine |
glucose-tolerant but not glucose-intolerant individuals upregulate their CAPN10 mRNA levels in response to prolonged exposure to fat |
664717 |
| 3.4.22.B30 | medicine |
the 2111 haplotype of calpain-10 with gene polymorphisms SNP-44 (rs2975760), -43 (rs3792267), -19 (rs3842570), and -63 (rs5030952) is associated with type 2 diabetes mellitus in an Asian Indian population in Southern India |
709822 |
| 3.4.22.B30 | medicine |
the calpain-10 single nucleotide polymorphism-63 (rs5030952C>T) and 1-1-2-haplotype (derived from SNP-43, SNP-19 and SNP-63) are associated with posttransplant diabetes mellitus |
710221 |
| 3.4.22.B30 | medicine |
the CAPN10 gene may play an important role in the pathogenesis of impaired fasting glucose/impaired glucose tolerance in essential hypertension patients |
708172 |
